• Charity News

Accelerating progress for everyone: our EDI in research strategic approach

We've published our refreshed equality, diversity and inclusion (EDI) in research strategic approach (2025). This data-driven blueprint will help us get closer to achieving our goal of beating cancer for everyone. We've published our refreshed equality, diversity and inclusion (EDI) in research strategic approach (2025). This data-driven blueprint will help us get closer to achieving our goal of beating cancer for everyone.

14 October 2025

• For Researchers

Cancer – a disease of ageing… until it isn’t

Cancer incidence increases with ageing – except in the very old, where rates of the disease drop. Why is that? Cancer incidence increases with ageing – except in the very old, where rates of the disease drop. Why is that?

8 October 2025

• For Researchers

Piecing together the puzzle of cancer inequalities

The issue of cancer inequality is layered, with differences in outcome at each stage of the cancer journey. But researchers are doing the work to put together the pieces of the puzzle… The issue of cancer inequality is layered, with differences in outcome at each stage of the cancer journey. But researchers are doing the work to put together the pieces of the puzzle…

2 October 2025

• For Researchers

The challenges of going international for CYP

International trials are vital to children’s and young people’s cancer research but can be notoriously difficult to set up. We get into the challenges… International trials are vital to children’s and young people’s cancer research but can be notoriously difficult to set up. We get into the challenges…

24 September 2025

• Policy & Insight

How Scotland and Wales can save thousands of lives from cancer

We've published our manifestos for cancer research and care in Scotland and Wales. They can help both countries reduce cancer death rates by 15% by 2040. We've published our manifestos for cancer research and care in Scotland and Wales. They can help both countries reduce cancer death rates by 15% by 2040.

24 September 2025

• For Researchers

A bridge for your career

Making the leap to form and lead your own lab can daunting – which is why CRUK created the Bridge to Academic Leadership (BAL) programme. Making the leap to form and lead your own lab can daunting – which is why CRUK created the Bridge to Academic Leadership (BAL) programme.

17 September 2025

• For Researchers

Level-up: Looking to epigenetics for the next immunotherapy breakthrough

Checkpoint inhibitors have utterly changed the immunotherapy landscape – but there could be a different kind of checkpoint just waiting to be targeted... Checkpoint inhibitors have utterly changed the immunotherapy landscape – but there could be a different kind of checkpoint just waiting to be targeted...

11 September 2025

• Charity News

2024/25 in review: Cancer Research UK accelerates progress to outsmart cancer

Our annual reports and accounts for 2024/25 show we are making good progress in our mission to beat cancer. Our annual reports and accounts for 2024/25 show we are making good progress in our mission to beat cancer.

8 September 2025

• For Researchers

Can uniting ageing and cancer research help cancer prevention?

The transition from normal to pre-cancerous tissue remains underexplored. Ageing research, by contrast, has long studied normal tissue decline... The transition from normal to pre-cancerous tissue remains underexplored. Ageing research, by contrast, has long studied normal tissue decline...

27 August 2025

• For Researchers

Minimally invasive, maximally effective: The rise of Interventional Oncology

From microbubbles to shorter hospital stays – Jim Zhong takes us through the incredible world of interventional oncology… From microbubbles to shorter hospital stays – Jim Zhong takes us through the incredible world of interventional oncology…

19 August 2025

• For Researchers

Is there a ribosomal weakness in cancer?

Once thought too conserved to be a therapeutic target for cancer, new insights could reveal ribosomal biogenesis to be an Achilles heel... Once thought too conserved to be a therapeutic target for cancer, new insights could reveal ribosomal biogenesis to be an Achilles heel...

9 July 2025